Bafna Pharmaceuticals Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

BAFNA Pharmaceuticals has announced a board meeting on matters related to the company's financial operations. They have provided a certificate from Cameo Corporate Services, confirming that all securities received for dematerialization in the quarter ending March 31, 2025, were processed according to regulations. This indicates compliance with operational standards, ensuring that securities are correctly handled and reflected in the register of members.

From an investor perspective, this update reinforces BAFNA's commitment to transparency and operational efficiency, contributing to a potentially positive outlook for shareholder confidence.